Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.4K Sell
17,915
-5,945
-25% -$9.04K ﹤0.01% 1426
2026
Q1
$43.2K Sell
23,860
-247
-1% -$427 ﹤0.01% 1161
2025
Q4
$32.5K Sell
24,107
-77
-0.3% -$110 ﹤0.01% 1257
2025
Q3
$39.4K Sell
24,184
-24,499
-50% -$27.1K ﹤0.01% 1176
2025
Q2
$47.2K Sell
48,683
-926
-2% -$768 ﹤0.01% 1073
2025
Q1
$35K Sell
49,609
-333
-0.7% -$230 ﹤0.01% 1114
2024
Q4
$40.2K Buy
+49,942
New +$45.7K ﹤0.01% 1052

Other funds holding OCGN

SBI Securities's OCGN Position: Q2 2026 in Review

SBI Securities reduced its Ocugen (OCGN) stake by 25% in Q2 2026, selling an estimated $9.04K and leaving 17,915 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1426.

SBI Securities first reported a position in OCGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $47.2K in Q2 2025. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • SBI Securities held 17,915 shares of Ocugen worth $27.4K as of Q2 2026.
  • SBI Securities sold 5,945 Ocugen shares in Q2 2026, an estimated $9.04K.
  • Ocugen made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1426 holding.
  • SBI Securities first reported a position in Ocugen in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Ocugen position peaked at $47.2K in Q2 2025.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.